Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Completed · Phase 3

Conditions studied: Hypertension

In brief

This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension

Key facts

Study ID

NCT00171535

Run by

Novartis

People needed

130

Starts

2004-10-01

Expected to finish

2005-04-01

Last updated by the study team

2011-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with severe hypertension

You may not qualify if…

• History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
• Liver, kidney, or pancreas disease
• Insulin dependent diabetes
• Allergy to certain medications used to treat high blood pressure
• Other protocol-defined inclusion/exclusion criteria may apply.

Where it is running

• Novartis Pharmaceuticals — East Hanover, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.